Beyond H2O: How Water Restructuring Could Reshape Modern Healthcare

Opinion |  Views | By Madhusudan Rajagopalan, CEO, Analemma Coherent Water | 0 Comment | 01 Sep, 2024

At first glance, water seems simple – two hydrogen atoms bonded ...Read more

3 Decades of Bioinformatics Advancements

Opinion |  Views | By Dr Ravi Gupta, Vice President – Bioinformatics, MedGenome | 0 Comment | 01 Sep, 2024

Major advancements    The Human Genome Project (HGP): C...Read more

Navigation Technology Trends in Healthcare

Opinion |  Views | By Arpit Paliwal, Director, HRS Navigation | 0 Comment | 01 Sep, 2024

Like all other sectors, technology has become a pivotal part of health...Read more

“Our priorities will include identifying and understanding the challenges while engaging regularly with industry leaders to address their concerns”

Opinion |  Interviews | 0 Comment | 01 Sep, 2024

How do you feel after being appointed as Director General at Pharmexci...Read more

“India is well-positioned to reduce its dependence on imported APIs and potentially challenge China's dominance in the global market”

Opinion |  Interviews | 0 Comment | 01 Sep, 2024

What are the primary challenges before the API sector in India, partic...Read more

“In India, the anti-snake venom market has historically been unregulated and often grouped under vaccine guidelines”

Opinion |  Interviews | By Amguth Raju | 0 Comment | 31 Jul, 2024

Could you please share the journey of Vins Bioproducts? How did it all...Read more

“We recommend innovative economic models to incentivise antibiotic research”

Opinion |  Interviews | By Dr Manbeena Chawla | 0 Comment | 31 Jul, 2024

What are your major plans for FY 2024-25 for the Indian and global mar...Read more

“We look forward to collaborate with government initiatives to promote degree programmes in biomedical innovation”

Opinion |  Interviews | By Dr Manbeena Chawla | 0 Comment | 31 Jul, 2024

Please highlight the recent collaborations signed by BFI for advancing...Read more

Transformative role of Indian pathology market in healthcare

Opinion |  Views | By Aryaman Tandon, Co-Founder and Managing Partner- Healthcare, Praxis Global Alliance | 0 Comment | 31 Jul, 2024

The Indian pathology market is valued at approximately $7.5 billion, a...Read more

Why global pharma companies choose India for GCCs

Opinion |  Views | By Anil Matai, Director General, Organisation of Pharmaceutical Producers of India (OPPI) | 0 Comment | 31 Jul, 2024

India serves as a key global hub for development, attracting investmen...Read more

Addressing Rare Disease Treatments with Biosimilars and Orphan Drugs

Opinion |  Views | By Surbhi Gupta, Industry Principal, Healthcare & Lifesciences, Frost & Sullivan | 0 Comment | 31 Jul, 2024

Governments across the world have regulatory incentives to support orp...Read more

Cementing India's place as global leader in biosimilars

Opinion |  Views | By Dr Sudhira H S, Director, Gubbi Labs | 0 Comment | 31 Jul, 2024

Biosimilars, also known as follow-on biologics, are the subsequent ver...Read more

The main challenge is resistance to change which we’re addressing through focused interventions and training: Dr Rajeev Raghuvanshi

Opinion |  Interviews | By Bhagwati Prasad, Mumbai  | 0 Comment | 06 Jul, 2024

Could you elaborate on the importance of data integrity in the pharmac...Read more

“Bioactive peptides, a significant antidiabetic drug, are set to come off patent in 2026 and our industry is gearing up for its production”

Opinion |  Interviews | By Bhagwati Prasad | 0 Comment | 03 Jul, 2024

How’s the recent growth in pharmaceutical and medical device exp...Read more

Macro Callouts for Healthcare Investing in India

Opinion |  Views | By Visalakshi Chandramouli, Managing Partner, Tata Capital- Healthcare Fund | 0 Comment | 30 Jun, 2024

India’s healthcare and life sciences sector is one of the fastes...Read more

Integrating Research Data for Drug Efficiency in the Indian Pharma Landscape

Opinion |  Views | By Dr Mary Donlan, Global lead- Product Marketing Team, Revvity Signals | 0 Comment | 30 Jun, 2024

The Indian pharmaceutical industry has emerged as a global powerhouse,...Read more

“GIMS will play a pivotal role in providing solutions for validation and trials for medtech startups in Uttar Pradesh”

Opinion |  Views | By Anusha Ashwin | 0 Comment | 30 Jun, 2024

GIMS Startup Centre for Medical Innovation is a public hospital-based ...Read more

“We anticipate starting sales of India’s first invented antibiotic drug combination of Cefepime and Enmetazobactam by the next quarter”

Opinion |  Interviews | By Dr Manbeena Chawla | 0 Comment | 30 Jun, 2024

What are the major plans in store for FY 24-25? How much growth is exp...Read more